Search results for "Serum ferritin level"

showing 4 items of 4 documents

Sequential alternating deferiprone and deferoxamine treatment compared to deferiprone monotherapy: main findings and clinical follow-up of a large mu…

2011

In β-thalassemia major (β-TM) patients, iron chelation therapy is mandatory to reduce iron overload secondary to transfusions. Recommended first line treatment is deferoxamine (DFO) from the age of 2 and second line treatment after the age of 6 is deferiprone (L1). A multicenter randomized open-label trial was designed to assess the effectiveness of long-term alternating sequential L1-DFO versus L1 alone iron chelation therapy in β-TM patients. Deferiprone 75 mg/kg 4 days/week and DFO 50 mg/kg/day for 3 days/week was compared with L1 alone 75 mg/kg 7 days/week during 5-year follow-up. A total of 213 thalassemia patients were randomized and underwent intention-to-treat analysis. Statisticall…

AdultMalemedicine.medical_specialtyAdolescentPyridonesThalassemiaClinical BiochemistryDeferoxamineIron Chelating AgentsGastroenterologyDrug Administration Schedulelaw.inventionchemistry.chemical_compoundYoung AdultRandomized controlled triallawInternal medicineMedicineHumansDeferiproneAdverse effectGenetics (clinical)Survival analysisbusiness.industryBiochemistry (medical)Serum ferritin levelbeta-ThalassemiaHematologyIron chelation therapymedicine.diseaseChelation TherapyDeferoxamineTreatment OutcomechemistryDrug Therapy CombinationFemalebusinessDeferiproneThalassemia Iron overload Iron chelation therapy Deferiprone (L1) Deferroxamine (DFO)medicine.drugFollow-Up StudiesHemoglobin
researchProduct

Magnetic resonance imaging of the pituitary gland in patients with secondary hypogonadism due to transfusional hemochromatosis

1999

To identify pituitary iron overload in patients with transfusional hemochromatosis causing secondary hypogonadism, we prospectively evaluated signal intensity abnormalities of the anterior lobe of the pituitary gland of 18 patients affected by transfusion-dependent thalassemia major and secondary hypogonadism. Magnetic resonance (MR) imaging is useful to assess pituitary iron overload in patients with transfusional hemochromatosis and secondary hypogonadism by detection of a significant decreased signal intensity of the anterior lobe of the pituitary gland on GRE T2*-weighted images. The decreased signal intensity of the anterior lobe of the pituitary gland on GRE T2*-weighted images was co…

AdultMalemedicine.medical_specialtyPathologyPituitary glandAdolescentThalassemiaBiophysicsPituitary InsufficiencyInternal medicinemedicineHumansRadiology Nuclear Medicine and imagingIn patientHemochromatosisRadiological and Ultrasound Technologymedicine.diagnostic_testbusiness.industryHypogonadismSerum ferritin levelTransfusion ReactionPterygoid MusclesMagnetic resonance imagingmedicine.diseaseMagnetic Resonance ImagingEndocrinologymedicine.anatomical_structurePituitary GlandFerritinsThalassemiaFemaleHemochromatosisbusinessHormoneMagma: Magnetic Resonance Materials in Physics, Biology, and Medicine
researchProduct

Hypogonadotrophic Pituitary Insufficiency in Transfusional Hemochromatosis Complicating Thalassemia Major: MR Imaging

1999

To identify pituitary iron overload in patients with transfusion-dependent thalassemia major causing secondary hypogonadism, we prospectively evaluated signal intensity abnormalities of the anterior lobe of the pituitary gland of 30 patients comparing spin-echo, gradient-echo imaging and pituitary T2 relaxation times measurement. We found that pituitary iron overload can best be assessed by MR imaging using gradient-echo T2*-weighted technique to establish signal reduction in the anterior lobe of the pituitary gland. This finding is correlated to increasing serum ferritin level — a parameter that reflects the severity of iron overload, and is more evident in patients with secondary hypogon…

Pituitary glandPathologymedicine.medical_specialtyRadiological and Ultrasound Technologybusiness.industryThalassemiaSerum ferritin levelPituitary Insufficiencymedicine.diseaseMr imagingmedicine.anatomical_structureT2 relaxationmedicineRadiology Nuclear Medicine and imagingIn patientNeurology (clinical)businessHemochromatosisRivista di Neuroradiologia
researchProduct

Circulating Levels of Ferritin, RDW, PTLs as Predictive Biomarkers of Postoperative Atrial Fibrillation Risk after Cardiac Surgery in Extracorporeal …

2022

Postoperative atrial fibrillation (POAF) is the most common arrhythmia after cardiac surgery in conventional extracorporeal circulation (CECC), with an incidence of 15–50%. The POAF pathophysiology is not known, and no blood biomarkers exist. However, an association between increased ferritin levels and increased AF risk, has been demonstrated. Based on such evidence, here, we evaluated the effectiveness of ferritin and other haematological parameters as POAF risk biomarkers in patients subjected to cardiac surgery. We enrolled 105 patients (mean age = 70.1 ± 7.1 years; 70 men and 35 females) with diverse heart pathologies and who were subjected to cardiothoracic surgery. Their blood sample…

cardiothoracic surgeryOrganic Chemistryconventional extracorporeal circulationpathology_pathobiologyGeneral Medicinepostoperative atrial fibrillation; cardiothoracic surgery; conventional extracorporeal circulation; serum ferritin levels; PW indices; POAF onset biomarkersPOAF onset biomarkersCatalysisComputer Science ApplicationsInorganic ChemistrySettore MED/23postoperative atrial fibrillationPhysical and Theoretical ChemistryPW indicesMolecular Biologyserum ferritin levelsSpectroscopyInternational journal of molecular sciences
researchProduct